好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Dopamine Agonist Withdrawal Syndrome (DAWS) in a Movement Disorders Clinic
Movement Disorders
(-)
005
Authors/Disclosures
No disclosure on file
Connie C. Marras, MD (Toronto Western Hospital) Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene.
Janis M. Miyasaki, MD, MEd, FAAN (University of Alberta/Alberta Health Services) Dr. Miyasaki has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Miyasaki has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Miyasaki has received research support from PCORI. The institution of Dr. Miyasaki has received research support from Brain Canada. The institution of Dr. Miyasaki has received research support from Canadian Consortium on Neurodegeneration in Aging. The institution of Dr. Miyasaki has received research support from University Hospital Foundation. The institution of Dr. Miyasaki has received research support from Social Science and Health Research Council.
Damian Consalvo, MD No disclosure on file
Elena Moro, MD, FAAN (Grenoble Alpes University) Dr. Moro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic, Abbott, Kyowa. Dr. Moro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Moro has received research support from Abbott. The institution of Dr. Moro has received research support from IPSEN.
Melissa Armstrong, MD, MSc, FAAN, FAAN (UF Department of Neurology) The institution of Dr. Armstrong has received research support from National Institute of Aging. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. Dr. Armstrong has received research support from Parkinson Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Antonio Strafella, MD No disclosure on file
Binit Shah, MD, FAAN (University of Virginia) Dr. Shah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Expert Institute.
Susan Fox, MD, FAAN (Toronto Western Hospital) The institution of Dr. Fox has received research support from MJFF/Safra. The institution of Dr. Fox has received research support from Parkinson Canada. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received publishing royalties from a publication relating to health care.
No disclosure on file
Nicolás Phielipp, MD (UCI Health, WEN center) No disclosure on file
Anthony E. Lang, MD, FAAN (Toronto Western Hospital) Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.